SCHEMBL3416142

SCHEMBL3416142

C=CC(F)n1cnc2c(Cl)nc(Cl)nc21

nearest known ligand 0.37

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ P2RX7 Q99572 2/20 0.37
▸ CCNA2 P20248 9/20 0.36
▸ CDK2 P24941 9/20 0.36
▸ CCNA1 P78396 9/20 0.36
▸ CDK5 Q00535 9/20 0.36
▸ CDK5R1 Q15078 9/20 0.36
▸ DYRK1A Q13627 7/20 0.36
▸ LMNA P02545 1/20 0.35
▸ TP53 P04637 1/20 0.35
▸ CDK1 P06493 2/20 0.34
▸ PDE8A O60658 3/20 0.34
▸ PDE2A O00408 1/20 0.34
▸ PDE4D Q08499 1/20 0.34
▸ KCNH2 Q12809 1/20 0.34
▸ PDE10A Q9Y233 1/20 0.34
▸ NPC1 O15118 1/20 0.33
▸ POLB P06746 1/20 0.33
▸ YTHDC1 Q96MU7 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25211412 0.82 P2RX7 (0.41) P2RX7CCNA2CDK2CCNA1CDK5
SCHEMBL539356 0.76 CDK2 (0.56) P2RX7CCNA2CDK2CCNA1CDK5
SCHEMBL29426182 0.76 CDK2 (0.56) P2RX7CCNA2CDK2CCNA1CDK5
SCHEMBL27897027 0.73 CDK2 (0.44) P2RX7CCNA2CDK2CCNA1CDK5
SCHEMBL4140683 0.72 P2RX7 (0.42) P2RX7LMNATP53CDK1PDE8A
SCHEMBL30148781 0.72 CDK1 (0.41) P2RX7CCNA2CDK2CCNA1CDK5
SCHEMBL1913380 0.72 CDK1 (0.41) P2RX7CCNA2CDK2CCNA1CDK5
SCHEMBL946328 0.71 ADORA2A (0.50) P2RX7CCNA2CDK2CCNA1CDK5
SCHEMBL30331956 0.71 ADORA2A (0.50) P2RX7CCNA2CDK2CCNA1CDK5
SCHEMBL1355050 0.69 P2RX7 (0.48) P2RX7LMNATP53PDE8ANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010059418-A1 SUBSTITUTED TRIAZINE AND PURINE COMPOUNDS, METHODS OF INHIBITING CRUZAIN AND RHODESAIN AND METHODS OF TREATING CHAGAS DISEASE AND AFRICAN TRYPANOSOMIASIS THE GOVERNMENT OF THE U.S.A. AS REPRESENTED BY THE SECRETARY OF THE DEPT. OF HEALTH & HUMAN SERVICES (US) 2010-05-27 — — WO disclosed
Send feedback